Cell culture media development and manufacturing company, Irvine Scientific, has expanded its manufacturing facility in Santa Ana, California, to increase its overall dry-powder production capacity.
Expansion
The multistep expansion included more space for the company’s animal component free (ACF) dry powder production area, additional impact milling capacity, the addition of a large-scale, pharmaceutical grade blender and higher throughput cleaning capacity of the ACF dry powder portion of the facility.
“We are excited about the capacity this provides our customers. With this addition, the identical continuous impact milling and blending technology in place at our two manufacturing plants, we can offer demonstrated scalability of powder manufacturing from as little as 6 kg in our Express Media Service group, to cGMP production lots now up to 7,000 kg. Minimising variation between lots, keeping production costs down, and fast delivery times of final product are key requirements for our customers. Increasing our production batch capacity up to 7,000 kg will help us meet these requirements,” said Tim Mullane, COO, Irvine Scientific. “Our long-term growth and capital investment strategy are designed to keep pace with the predicted increases in demand for high quality cell culture media now and in the future.”